MOESM10 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Additional file 10: Figure S8. The Kaplan–Meier survival analysis of the signature for LUAD subgroup patients in GSE31210 dataset. Patients of high-risk exhibited poor prognosis in stage I cohort (P < 0.05). There was no association of the risk score with patients of stage II cohort, recurrence cohort, and no recurrence cohort.